Roadman Investments Enters Into Definitive Agreement for Acquisition of CLOV Biopharma Corp.
VANCOUVER, British Columbia, Feb. 14, 2020 -- Roadman Investments Corp. (LITT.V)(FWB:1QD)(RMANF) (“Roadman Investments” or the “Company”) is pleased to announce that, further to its press release of February 12, 2020, it has now entered into a Definitive Agreement (the “Agreement”) pursuant to which it has acquired all of the issued and o... Read More...